Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?
Portfolio Pulse from
Five biotech companies, AXSM, HALO, FOLD, BMRN, and INSM, are set to release their Q4 2024 earnings this week. Investors are keen to see if these companies will surpass earnings forecasts.
February 17, 2025 | 3:45 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AXSM is among the biotech companies releasing Q4 2024 earnings this week. Investors are watching to see if it will surpass forecasts.
AXSM is directly mentioned as one of the companies releasing earnings. The outcome could impact its stock price depending on whether it meets or exceeds expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
BMRN is among the biotech firms releasing Q4 2024 earnings this week. The market is keen to see if it will exceed expectations.
BMRN is set to release earnings, which could impact its stock price based on the results.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
FOLD will release its Q4 2024 earnings this week. Investors are watching closely to see if it will beat forecasts.
FOLD is mentioned as releasing earnings. The stock's short-term movement will depend on the earnings results.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
HALO is set to announce its Q4 2024 earnings this week. The market is eager to see if it will exceed earnings forecasts.
HALO is one of the companies releasing earnings. The stock price could be influenced by the earnings results.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
INSM will announce its Q4 2024 earnings this week. Investors are eager to see if it will surpass forecasts.
INSM is mentioned as releasing earnings. The stock's short-term movement will depend on the earnings results.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100